Drug profile · INN
ranibizumab
SUSVIMO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ranibizumab (SUSVIMO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN ranibizumab
Brand SUSVIMO
Route INJECTION
Formulation INJECTABLE
ATC code S01LA04
Frequently asked questions
What is ranibizumab?
ranibizumab (SUSVIMO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ranibizumab?
SUSVIMO is a marketed brand name for ranibizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ranibizumab?
ranibizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.